Header Logo

Sheila Dowd

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Phobia, Social
4
2023
13
0.720
 Why?
Cycloserine
5
2023
26
0.680
 Why?
Implosive Therapy
4
2023
19
0.580
 Why?
Transcranial Magnetic Stimulation
6
2015
17
0.390
 Why?
Depressive Disorder, Major
4
2015
93
0.330
 Why?
Antimetabolites
3
2019
12
0.310
 Why?
Clonazepam
3
2003
26
0.300
 Why?
Treatment Outcome
10
2023
3400
0.210
 Why?
Flunitrazepam
1
2002
1
0.200
 Why?
Substance Abuse Treatment Centers
1
2002
2
0.200
 Why?
GABA Modulators
1
2002
4
0.200
 Why?
Rape
1
2002
5
0.200
 Why?
Anti-Anxiety Agents
1
2002
38
0.190
 Why?
Antibiotics, Antitubercular
1
2020
2
0.170
 Why?
Adult
12
2021
7666
0.140
 Why?
Antidepressive Agents
2
2015
90
0.140
 Why?
Extinction, Psychological
3
2023
12
0.140
 Why?
Electroconvulsive Therapy
3
2007
16
0.130
 Why?
Double-Blind Method
4
2020
393
0.120
 Why?
Depressive Disorder, Treatment-Resistant
1
2015
9
0.120
 Why?
Panic Disorder
1
2016
134
0.120
 Why?
Humans
16
2023
25973
0.110
 Why?
Depressive Disorder
2
2007
172
0.110
 Why?
Combined Modality Therapy
3
2023
297
0.100
 Why?
Phobic Disorders
1
2013
66
0.100
 Why?
Behavior Therapy
1
2013
86
0.100
 Why?
Fear
2
2023
46
0.100
 Why?
Anxiety Disorders
2
2023
169
0.090
 Why?
Sleep Wake Disorders
1
2013
118
0.090
 Why?
Female
11
2020
14735
0.090
 Why?
Male
10
2020
14280
0.090
 Why?
Middle Aged
9
2016
8775
0.080
 Why?
Psychiatric Status Rating Scales
4
2013
296
0.070
 Why?
Placebos
2
2020
65
0.070
 Why?
Anticonvulsants
2
2007
54
0.060
 Why?
Attention
2
2003
106
0.060
 Why?
Severity of Illness Index
2
2020
870
0.050
 Why?
Substance Abuse Detection
1
2003
4
0.050
 Why?
Electric Stimulation
1
2003
50
0.050
 Why?
Forensic Medicine
1
2002
1
0.050
 Why?
Hair
1
2002
3
0.050
 Why?
Anxiety
1
2023
146
0.050
 Why?
Pilot Projects
2
2015
390
0.050
 Why?
Recurrence
2
2015
300
0.050
 Why?
Cognition Disorders
2
2007
957
0.040
 Why?
Memory
1
2002
285
0.040
 Why?
Drug Administration Schedule
1
2020
160
0.040
 Why?
Young Adult
2
2016
1942
0.040
 Why?
Galvanic Skin Response
1
2019
7
0.040
 Why?
Placebo Effect
1
2019
10
0.040
 Why?
Photic Stimulation
1
2019
23
0.040
 Why?
Mental Recall
1
2019
61
0.040
 Why?
Case-Control Studies
1
2020
572
0.040
 Why?
Prospective Studies
2
2015
1702
0.040
 Why?
Time Factors
2
2015
1391
0.030
 Why?
Retreatment
1
2015
8
0.030
 Why?
Watchful Waiting
1
2015
12
0.030
 Why?
Drug Resistance
1
2015
46
0.030
 Why?
Feasibility Studies
1
2015
210
0.030
 Why?
Gas Chromatography-Mass Spectrometry
2
2003
11
0.030
 Why?
Predictive Value of Tests
1
2013
466
0.020
 Why?
Comorbidity
1
2013
476
0.020
 Why?
Adolescent
2
2011
2100
0.020
 Why?
Kaplan-Meier Estimate
1
2010
174
0.020
 Why?
Aged
2
2015
8732
0.020
 Why?
Clinical Trials as Topic
1
2007
210
0.020
 Why?
Research Design
1
2007
183
0.020
 Why?
Follow-Up Studies
1
2010
1758
0.010
 Why?
Age Factors
1
2007
757
0.010
 Why?
Reference Standards
1
2003
22
0.010
 Why?
Calibration
1
2003
20
0.010
 Why?
Reaction Time
1
2003
91
0.010
 Why?
Memory, Short-Term
1
2003
91
0.010
 Why?
Electromagnetic Fields
1
2002
9
0.010
 Why?
Psychomotor Performance
1
2003
179
0.010
 Why?
Sensitivity and Specificity
1
2003
473
0.010
 Why?
Motor Activity
1
2003
317
0.010
 Why?
Neuropsychological Tests
1
2003
1150
0.010
 Why?
Dowd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_